Lone Star Value Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Lone Star Value Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-575,000	Closed	-$2.62M	–	18
2016 Q1	$2.62M	Sell	575,000 -25,000	-4%	-$111K	6.3%	4
2015 Q4	$2.7M	Sell	600,000 -150,000	-20%	-$633K	5%	8
2015 Q3	$2.38M	Buy	750,000 +729,000	+3,471%	+$2.21M	4.53%	9
2015 Q2	$64K	Buy	+21,000	New	+$59K	0.09%	19

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Lone Star Value Management's ENZ Position: Q2 2016 in Review

Lone Star Value Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2016, closing a stake of 575,000 shares — an estimated $2.62M sold.

Lone Star Value Management first reported a position in ENZ in Q2 2015 and held it in 4 quarters. The position peaked at $2.7M in Q4 2015. 104 funds tracked by Wall St. Rank hold ENZ as of Q2 2016.

Lone Star Value Management reported no remaining Enzo Biochem, Inc. position as of Q2 2016 after selling out during the quarter.
Lone Star Value Management sold 575,000 Enzo Biochem, Inc. shares in Q2 2016, an estimated $2.62M.
Lone Star Value Management first reported a position in Enzo Biochem, Inc. in Q2 2015 and held it in 4 quarters.
Lone Star Value Management's Enzo Biochem, Inc. position peaked at $2.7M in Q4 2015.
104 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2016.

Based on Lone Star Value Management's 13F filing for Q2 2016, filed 15 Aug 2016.